Clinical TrialID 2541
Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP
NCT03998982
Immune Thrombocytopenia
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 2541
- Evidence Id
- 2541
- Core Evidence Id
- 2541
- Source Clinical Trial Id
- 2520
- Herb2 Clinical Trial Id
- HBCT002520
- Nct Id
- NCT03998982
- Title
- Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP
- Status
- Phase
- Phase 4
- Study Result
- No
- Study Condition
- Immune Thrombocytopenia
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Glycyrrhetinic Acid|DRUG: Dexamethasone
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 30
- Outcome Measure
- Sustained response to ITP treatments, Percentage of patients maintaining PLT count over 30\*10\^9 without bleeding, 3 months after treatment started
- Sponsor Collaborator
- Shandong University
- Funded By
- OTHER
- Location
- Qilu hospital, Shandong University, Jinan, Shandong, 250012, China
- Other Id
- Glycyrrhetinic Acid+DXM in ITP
- Start Date
- 2019-06-25
- Primary Completion Date
- 2021-06-10
- Completion Date
- 2021-06-10
- First Posted
- 2019-06-26
- Results First Posted
- Last Update Posted
- 2021-06-11
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT03998982
- Title Cn
- Title En
- Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP
- Bilingual Status
- semi_complete